Oxford BioTherapeutics
  • ABOUT
    • COMPANY OVERVIEW
    • SENIOR LEADERSHIP >
      • MANAGEMENT
      • BOARD OF DIRECTORS
      • INVESTORS
    • OFFICES & LABS
    • Careers
  • IO DISCOVERY
    • IMMUNE CHECKPOINT TARGETS
    • IO ANTIBODY ENGINEERING
  • PIPELINES
  • NEWS
  • CONTACT

Investors

Oxford BioTherapeutics has completed a number of successful investment rounds, and is supported by a syndicate of leading specialist investors. In addition to this equity funding, a significant proportion of the outgoing investment into our innovative IO and antibody-drug conjugate pipelines is generated through our strategic alliances with leading companies in the sector. Our investors include a number of specialists:  
Picture
Picture
Picture

Privacy Policy

Legal Notice

Site Map

© 2017 Oxford BioTherapeutics All Rights Reserved
  • ABOUT
    • COMPANY OVERVIEW
    • SENIOR LEADERSHIP >
      • MANAGEMENT
      • BOARD OF DIRECTORS
      • INVESTORS
    • OFFICES & LABS
    • Careers
  • IO DISCOVERY
    • IMMUNE CHECKPOINT TARGETS
    • IO ANTIBODY ENGINEERING
  • PIPELINES
  • NEWS
  • CONTACT